After treatment with MPS of 85 cases suffering from malignant neoplasms treated with chemotherapy after operation , the level of leukocytes and the cell mediated immunity were raised obviously (P< 0. 05～ 0. 01 ) .
Compared with the population of the same region,they had the lower risk of death from all causes( SMR=0.63,P <0.05,healthy worker effect),but no significant difference in the risk of malignant neoplasms( SMR=0.88,P> 0.05).
Objective To compare the level of IL-12 and IL-10 secreted by DC sitimulated with CpG-ODN and BCG,and to investigate the role of new immunologic adjuvant CpG-ODN in preventing the recurrence of bladder neoplasms.
1.Construction of Fusion Gene Coding for RGD Peptide and Urokinase B Chain and Its Expression in Escherichia Coli and Characterization 2.The Study on Suppression of Metastatic Potential of Cancer Cells with Urokinase Amino-terminal Fragment Gene Tran
After the fusion protein was purified by affinity chromatography the protein was transducted into A549 cells using lipofectamineTM 2000. The results of growth curve and flow cytometry demonstrated that P16 protein could inhibit the growth of the cancer cells.
METHODS: From September 2005 to January 2006, the preparation and disposal of SIS and combined cultivation of PIEC and SIS were conducted in the Institute of Biomedical Engineering, School of Life Science and Technology, Tongji University; meanwhile, the radial irradiation and disinfection for SIS was conducted at the Cancer Center of Zhongshan Hospital Fudan University.
Guanidine-like compounds have been investigated since the first observations of their therapeutic potential some 30 years ago in fields of cancer and virology.
Epidermal Growth Factor Receptor (EGFR) is among the growth factor receptor kinases that have been implicated in as being important in cancer.
Inhibitive Effect of Prodigiosin on the Proliferation of Human Malignant Pancreatic Cancer Cells
Pancreatic cancer is not only common, but also extremely difficult to treat, for which it has been called "the challenge of the twenty-first century".
In this study, we find that prodigiosin could effectively inhibit the proliferation of human pancreatic cancer cells H8898 in a dose-and-time-dependent manner, with an IC50 of 75μmol according to the results of MTT and cell proliferation assays.